Wednesday, August 12, 2020
Tags Akarna Therapeutics

Tag: Akarna Therapeutics

Popular Articles

Family offices give VC vote of confidence amid Covid-19 crisis – but returns expectations...

Family offices are sticking with venture capital despite the growing coronavirus crisis - but their expectations of returns threw up a surprising result, new research shows.

US companies should consider making slavery reparations, says Vista Equity Partners CEO

Vista Equity Partners CEO Robert Smith has said that companies which profited from the transatlantic slave trade should consider making reparations to African-Americans.

Churchill Real Estate picks up $2bn of new institutional capital

Churchill Real Estate has picked up $2bn of new institutional capital as it looks to capitalise on residential transition lending.

Stellex Capital Management brings in industry veteran pair for launch of Michigan office

Mid-market US private equity house Stellex Capital Management has expanded its operations through the opening of a new office in Michigan.

One Equity Partners picks up wound care, medical procedure specialist American Medical Technologies

One Equity Partners has picked up advanced wound care and medical procedure supplies and services company American Medical Technologies.

Advent Life Sciences seals KaNDy sale to industry giant Bayer, deal could be worth...

Europe's Advent Life Sciences has sealed a sale of KaNDy Therapeutics Ltd to industry giant Bayer in a deal which could see it collect in excess of $975m.

Arcline Investment Management makes Jersey Elevator latest buyout from $1.5bn debut fund

Arcline Investment Management has picked up elevator maintenance, modernization and installation Jersey Elevator.

Industry giants, Skype co-founder Zennström among big-name backers of La Famiglia’s sophomore fundraise

Industry giant Mittal, the Swarovski family and Skype co-founder Niklas Zennström are all among backers of a €50m fund raised by woman-led venture capital firm La Famiglia.

Perimeter raises rapid-fire $40m Series B, just months after Series A extension

Zero-trust secure network Perimeter 81 has closed its Series B on $40m, just a few months after a Series A extension.

Proptech startup Habito secures £35m in venture capital-backed Series C round

London-based PropTech Habito has bagged £35m in a Series C round led by Augmentum Fintech, SBI Group and

Get the latest PE News & Research delivered to your inbox every morning